Axa’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q2 | – | Sell |
-176,224
| Closed | -$17.2M | – | 1518 |
|
2015
Q1 | $17.2M | Buy |
176,224
+25,497
| +17% | +$2.49M | 0.07% | 287 |
|
2014
Q4 | $14M | Buy |
150,727
+7,067
| +5% | +$656K | 0.06% | 322 |
|
2014
Q3 | $9.88M | Buy |
143,660
+19,527
| +16% | +$1.34M | 0.04% | 380 |
|
2014
Q2 | $13M | Sell |
124,133
-3,928
| -3% | -$412K | 0.05% | 349 |
|
2014
Q1 | $10.6M | Buy |
128,061
+4,230
| +3% | +$351K | 0.05% | 368 |
|
2013
Q4 | $8.01M | Buy |
123,831
+20,865
| +20% | +$1.35M | 0.04% | 418 |
|
2013
Q3 | $6.52M | Buy |
102,966
+34,788
| +51% | +$2.2M | 0.03% | 460 |
|
2013
Q2 | $2.86M | Buy |
+68,178
| New | +$2.86M | 0.02% | 618 |
|